MedPath

Impact of remote ischemic preconditioning (RIPC) on kidney function and microRNA-signature of extracellular vesicles following partial nephrectomy: a randomized, prospective trial

Not Applicable
Conditions
C64
Malignant neoplasm of kidney, except renal pelvis
Registration Number
DRKS00030081
Lead Sponsor
Marien Hospital Herne
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
170
Inclusion Criteria

kidney tumor
- partial nephrectomy technically feasible

Exclusion Criteria

intraoperative conversion to nephrectomy

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Postoperative renal function (measured as creatinine, 24 hour-urine, cystatin C und the following biomarkers in plasma and urine: IGFBP7, TIMP-2, KIM-1, NGAL, Vanin-1, NAG, uRBP4, DKK-3) at 24h, 3 and 90 days postoperatively
Secondary Outcome Measures
NameTimeMethod
Concentration of EV and microRNA-signature from plasma at the following time points:<br>T1: Before anesthesia<br>T2: 5 minutes after RIPC<br>T3: 5 minutes before clamping of renal artery<br>T4: 5 minutes after declamping<br>T5: end of operation
© Copyright 2025. All Rights Reserved by MedPath